openPR Logo
Press release

Schizophrenia Drugs Market Growth, Size, Opportunity, Share and Forecast 2019-2025

05-13-2020 03:01 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Schizophrenia Drugs Market

Global Schizophrenia Drugs Market

The global schizophrenia drugs market is projected to exhibit a modest growth, at a CAGR of around 2.7%, during the forecast period. There has been a rise in stress management and mental health awareness initiatives across the globe. The need for these awareness programs is necessary as well due to the increasing level of mental disorders due to high stress in individuals. There are various organizations and educational institutions such as ALAS Pro Salud Mental and Stanford University that have taken immense steps to spread awareness programs. These programs are assisting individuals to notice behaviour change and other stress-related symptoms in their daily lives on accounts of which the demand for schizophrenia drugs is expected to increase in the near future.

Request a Free Sample of our Report on Schizophrenia Drugs Market: https://www.omrglobal.com/request-sample/schizophrenia-drugs-market

Mental health conditions have concerned various organizations and one of them is WHO. According to WHO, the status of mental health care varies widely from one country to another country. Many countries already have policies to deliver services for mental health conditions in primary care settings; however, they require system strengthening to achieve integration. Further, by 2023, the WHO Special Initiative for Mental Health is expected to increase treatment coverage for mental health conditions by ensuring access to mental health care for 100 million more people over its 5-year plan. This plan intends to contribute to the broader GPW13 targets for increasing service coverage for severe mental health conditions to 50% and reducing suicide mortality by 15%. This initiative is expected to offer growth to the schizophrenia drugs market during the forecast period.

According to the World Economic Forum, the loss of work output due to mental health is the highest across the globe. The mental health contributes a huge 35% of total work loss due to increasing prevalence of diseases across the globe. Further, according to WHO, more than 80% of people with mental health conditions, including people with neurological and substance use disorders, are without any form of quality, or affordable mental healthcare. Hence the government is taking several initiatives taking mental health in mind to overcome the economic losses that are a result of increased stress levels. Thus, the increase in government-run initiatives to create awareness related to stress management is anticipated to drive the market growth in the near future.

Further, Stanford University launched an initiative in 2018. The initiative's goal is to establish and maintain a forum to tackle global mental health as a priority. This program would combine activities focused on global mental health in healthcare, science, sports, and education which is expected to immensely assist the growth of schizophrenia drugs market. In addition, the new program would draw together the current activities of the faculty and provide opportunities for new collaborations and initiatives. A core component of the project is the use of IT resources to extend mental health programs across the globe, taking advantage of Silicon Valley's expertise.

A Full Report of Schizophrenia Drugs Market is Available at https://www.omrglobal.com/industry-reports/schizophrenia-drugs-market

Global Schizophrenia Drugs Market-Segmentation

By Type
o Second-Generation Antipsychotics
o Third-Generation Antipsychotics
o Others

By Treatment
o Oral
o Injectables

Global Schizophrenia Drugs Market- Segment by Region

North America
o United States
o Canada

Europe
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe

Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

Company Profiles
o AiCure, LLC
o Alkermes PLC
o Allergan PLC
o AstraZeneca PLC
o Biogen Inc.
o Catalent, Inc.
o Eli Lilly and Co.
o H. Lundbeck A/S
o Indivior PLC
o Johnson & Johnson Services, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/schizophrenia-drugs-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Schizophrenia Drugs Market Growth, Size, Opportunity, Share and Forecast 2019-2025 here

News-ID: 2044405 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Schizophrenia

Rising Mental Illness Burden Fuels Growth In The Schizophrenia Market: Pivotal F …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Schizophrenia Market Size Growth Forecast: What to Expect by 2025? In the past few years, the schizophrenia market size has seen robust growth. The projected growth from $5.82 billion in 2024 to $6.11 billion in 2025, signifies a compound annual growth rate (CAGR) of 5.0%. Factors such as increased
Clozapine Market: Transforming the Treatment Landscape for Schizophrenia
Clozapine, an atypical antipsychotic medication, has emerged as a critical treatment option for patients with treatment-resistant schizophrenia and other severe psychiatric disorders. As one of the most effective therapies available for reducing symptoms in individuals who do not respond adequately to other antipsychotic medications, clozapine plays a vital role in modern psychiatry. This article provides a comprehensive overview of the clozapine market, exploring market information, key trends, challenges, and detailed
Schizophrenia Drugs Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: Schizophrenia Drugs Market was valued at USD 5.3 Billion in 2018 and is projected to reach USD 8.42 Billion by 2026, growing at a CAGR of 3.66% from 2019 to 2026. Market Overview for Schizophrenia Drugs Market Schizophrenia Drugs Market OverviewThe schizophrenia drugs market is experiencing significant growth driven by advancements in pharmacotherapy and increasing awareness about mental health disorders. Schizophrenia, a chronic and severe mental disorder affecting millions
Schizophrenia Drugs Market - Restoring Balance, Inspiring Hope: Schizophrenia Dr …
Newark, New Castle, USA: The "Schizophrenia Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Schizophrenia Drugs Market: https://www.growthplusreports.com/report/schizophrenia-drugs-market/7871 This latest report researches the industry structure, sales, revenue,
Schizophrenia Drugs Market - Leading the Way in Schizophrenia Treatment: Nurturi …
Newark, New Castle, USA - new report, titled Schizophrenia Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Schizophrenia Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Schizophrenia Drugs market. The report offers an overview of the market, which
Schizophrenia Drug Market & Pipeline Insight
Schizophrenia is defined as a disorder of the brain which impacts the way in which a person acts, thinks, and sees the world. It has been observed that the patients suffering from schizophrenia generally tend to have an altered perception of reality, which reveals a significant diversion from the reality. In most cases, schizophrenia is diagnosed among people in the late teens or early adulthood. However, middle-aged people also could